DOGWOOD THERAPEUTICS INC. - COMMON STOCK

11.40

24-January-25 16:45:00

15 minutes delayed

Stocks

-1.95

-14.61%

Today's range

10.10 - 19.33

ISIN

N/A

Source

NASDAQ

Dogwood Therapeutics Announces Patient Dosing in Phase 2b Trial Evaluating Halneuron® in Patients with Chemotherapy Induced Neuropathy (CINP) to Commence First Quarter of 2025

21 Jan 2025 09:15:00 By Nasdaq GlobeNewswire
Dogwood Therapeutics, Inc. Announces Low Dose IMC-2 Treatment Reduces Long-COVID Related Fatigue and Sleep Disturbance in an Investigator-Initiated Study

18 Nov 2024 08:45:00 By Nasdaq GlobeNewswire
Dogwood Therapeutics Announces Third Quarter 2024 Financial Results

07 Nov 2024 07:05:00 By Nasdaq GlobeNewswire
Dogwood Therapeutics to Report Third Quarter 2024 Financial Results and Provide Corporate Update on Thursday, November 7, 2024

31 Oct 2024 09:15:00 By Nasdaq GlobeNewswire
Dogwood Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement

30 Oct 2024 09:15:00 By Nasdaq GlobeNewswire

<<
<
1
>

I Agree NetDania's website uses cookies. By continuing browsing our website, you agree to our Cookie Policy, Privacy Policy and Terms and Conditons.